相关实验视频

Updated: Jul 12, 2025

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

通过疾病进展和有效的肉毒素治疗解释的"伪"二次治疗失败:试点模拟研究

Harald Hefter¹, Dietmar Rosenthal¹, Sara Samadzadeh^1,2,3,4

¹Departments of Neurology, University of Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany.

|October 27, 2023

概括

在毒神经毒素 (BoNT) 治疗焦点 dystonia 后的二次恶化可能是伪二次治疗失败,而不是抗体诱导. 在诊断真正的治疗失败之前,剂量调整是关键.

科学领域:

神经学神经学
药理学药理学是指药理学的学科.

背景情况:

在最初的肉毒神经毒素 (BoNT) 反应后,焦点性 dystonia 患者可能会经历二次恶化.
这种恶化通常归因于抗体诱导的二次治疗失败 (NAB-STF).

研究的目的:

模拟和分析毒神经毒素 (BoNT) 治疗焦点 dystonia 的长期结果.
要区分抗体诱导的二次治疗失败 (NAB-STF) 和伪二次治疗失败 (PSEUDO-STF).

主要方法:

开发了一个四步模拟模型来表示BoNT长期治疗结果.
该模型结合了单次BoNT注射 (SI曲线) 和疾病进展 (PRO曲线) 的影响.

主要成果:

模拟表明,由于BoNT疗效与疾病进展之间的相互作用,最初的改善随后的次要恶化可能会发生.
这种称为伪二次治疗失败 (PSEUDO-STF) 的模式取决于疾病进展的急剧程度和初始治疗的持续时间.
通过调整BoNT剂量,可以潜在地管理PSEUDO-STF.

结论:

在BoNT治疗的焦点 dystonia中,二次恶化可能代表PSEUDO-STF而不是NAB-STF.
在诊断真正的二次治疗失败之前,应考虑剂量调整.

关键词:

毒素作用的持续时间焦点 dystonia 焦点 dystonia 焦点 dystonia 焦点 dystonia 焦点 dystonia 焦点 dystonia 焦点 dystonia 肉毒神经毒素治疗的长期结果.中和抗体中和抗体.二次处理失败的第二次处理失败.模拟模拟是指一个模拟模拟.

更多相关视频

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

相关概念视频

Depolarizing Blockers: Pharmocokinetics

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...